White Paper

Don't Settle For Less. Redefining The Core And Scope Of Study Startup

chart data analytics tablet

Technology designed to improve study startup is at the forefront of expanding this niche through initiatives that drill down to the granular level, which helps identify potential bottlenecks and other factors that could derail studies.

With nearly half of clinical trial costs unaccounted for, including known administrative costs, and much of those linked to study startup, it is telling that the industry is finally moving toward identifying those costs with the help of purpose-built tools that can determine, with a high degree of accuracy, when it is time to stop identifying sites.

This change in approach will continue to highlight how improving the study startup process is a great opportunity, yielding a major impact on quality, timeline and overall cost of clinical trials.

This white paper focuses on defining and expanding the definition of study startup, an element of clinical trials that is gaining attention because it offers the greatest opportunity to improve quality while compressing clinical trial timelines.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: